Authors:
BARDITCHCROVO P
NOE D
SKOWRON G
LEDERMAN M
KALAYJIAN RC
BORUM P
BUIER R
ROWE WB
GOLDBERG D
LIETMAN P
Citation: P. Barditchcrovo et al., A PHASE I II EVALUATION OF ORAL L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACIDIN ASYMPTOMATIC PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/, Journal of clinical pharmacology, 38(4), 1998, pp. 357-363
Authors:
SKOWRON G
COLE BF
ZHENG D
ACCETTA G
YENLIEBERMAN B
Citation: G. Skowron et al., GP120-DIRECTED ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY AS A MAJOR DETERMINANT OF THE RATE OF DECLINE IN CD4 PERCENTAGE IN HIV-1 DISEASE, AIDS, 11(15), 1997, pp. 1807-1814
Authors:
MIKOLICH DJ
KINSELLA LJ
SKOWRON G
FRIEDMAN J
SUGAR AM
Citation: Dj. Mikolich et al., ASPERGILLUS MENINGITIS IN AN IMMUNOCOMPETENT ADULT SUCCESSFULLY TREATED WITH ITRACONAZOLE, Clinical infectious diseases, 23(6), 1996, pp. 1318-1319
Citation: G. Skowron, BIOLOGIC EFFECTS AND SAFETY OF STAVUDINE - OVERVIEW OF PHASE-I AND PHASE-II CLINICAL-TRIALS, The Journal of infectious diseases, 171, 1995, pp. 113-117
Authors:
KALAYJIAN RC
SKOWRON G
EMGUSHOV RT
CHANCE M
SPELL SA
BORUM PR
WEBB LS
MAYER KH
JACKSON JB
YENLIEBERMAN B
STORY KO
ROWE WB
THOMPSON K
GOLDBERG D
TRIMBO S
LEDERMAN MM
Citation: Rc. Kalayjian et al., A PHASE I II TRIAL OF INTRAVENOUS L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID (PROCYSTEINE) IN ASYMPTOMATIC HIV-INFECTED SUBJECTS/, Journal of acquired immune deficiency syndromes, 7(4), 1994, pp. 369-374
Citation: G. Skowron, HIV-1 ENV-SPECIFIC CELLULAR CYTOTOXICITY IN HIV-1-SEROPOSITIVE MOTHERS AND THEIR INFANTS, AIDS research and human retroviruses, 10, 1994, pp. 190000079-190000082
Authors:
LIU M
FAHEY JL
AZIZ N
CUMBERLAND WG
SKOWRON G
MERIGAN T
Citation: M. Liu et al., ZIDOVUDINE AND DIDEOXYCYTIDINE DIFFER IN THEIR EFFECTS ON HUMAN IMMUNODEFICIENCY VIRUS-INDUCED PATHOLOGICAL ACTIVATION OF THE IMMUNE-SYSTEM, The Journal of infectious diseases, 170(5), 1994, pp. 1165-1171